Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diazepam for catatonia.

J P McEvoy, J B Lohr

    The American Journal of Psychiatry
    |February 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Diazepam quickly resolved catatonic immobility in schizophrenic patients. This medication may offer an effective, readily available treatment for severe catatonic disorders.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Childhood Trauma in People with Psychosis: Implications for Emotion Awareness and Regulation.

    Psychosis·2025
    Same author

    Persistent infection with neurotropic herpes viruses and cognitive impairment.

    Psychological medicine·2012
    Same author

    Heritability of functioning in families with schizophrenia in relation to neurocognition.

    Schizophrenia research·2012
    Same author

    Comparative effectiveness of antipsychotic drugs in schizophrenia.

    Dialogues in clinical neuroscience·2011
    Same author

    Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study.

    Current pharmacogenomics and personalized medicine·2011
    Same author

    Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

    Molecular psychiatry·2010
    Same journal

    2026 Annual Meeting: President-Elect Address.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: CEO and Medical Director's Address.

    The American journal of psychiatry·2026
    Same journal

    Reports to the Membership.

    The American journal of psychiatry·2026
    Same journal

    Convergent Metabolic Dysregulations But Divergent Contributing Pathways Across Severe Mental Disorders: The Power of Combining Genetics and Metabolomics.

    The American journal of psychiatry·2026
    Same journal

    2026 Annual Meeting: Presidential Address.

    The American journal of psychiatry·2026
    Same journal

    Represcribing Previously Used Antipsychotics: Response to So.

    The American journal of psychiatry·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Pharmacology

    Background:

    • Catatonia is a severe neuropsychiatric syndrome characterized by motor abnormalities.
    • Treatment options for catatonia can be limited, necessitating exploration of effective interventions.

    Observation:

    • Two patients with schizophrenia experiencing catatonic immobility were treated with intravenous diazepam.
    • The treatment resulted in rapid and complete resolution of catatonic symptoms.

    Findings:

    • Intravenous diazepam demonstrated immediate efficacy in alleviating catatonic immobility.
    • Oral diazepam successfully maintained the therapeutic benefits, preventing relapse.

    Implications:

    • Diazepam presents a potentially life-saving and accessible treatment for patients with severe catatonic disorders.
    • Further research into diazepam's role in managing catatonia is warranted.